by Summary:
Since dorzagliatin is supposed to “repair” patients’ damaged insulin regulating function, it can potentially be a “cure” for some patients, who will not need the drug after certain period of intake. Existing drugs only lower3 blood sugar when the need arises. SCMP Eric Ng - Why are investors offloading Hua Medicine stock which is close to launching a novel diabetes drug?
Topics:
Mike Norman considers the following as important:
This could be interesting, too:
Since dorzagliatin is supposed to “repair” patients’ damaged insulin regulating function, it can potentially be a “cure” for some patients, who will not need the drug after certain period of intake. Existing drugs only lower3 blood sugar when the need arises.Since dorzagliatin is supposed to “repair” patients’ damaged insulin regulating function, it can potentially be a “cure” for some patients, who will not need the drug after certain period of intake. Existing drugs only lower3 blood sugar when the need arises. SCMP Eric Ng - Why are investors offloading Hua Medicine stock which is close to launching a novel diabetes drug?
Topics:
Mike Norman considers the following as important:
This could be interesting, too:
NewDealdemocrat writes Repeat home sale prices accelerated in February (but don’t fret yet)
Angry Bear writes Sorta a book review “Wall Street’s War on Workers”
NewDealdemocrat writes Looking at historical “mid cycle indicators” – what do they say now?
Ken Houghton writes 2024 Election Life and Death Game Theory: Post- Conventions (full text)
SCMP
Eric Ng - Why are investors offloading Hua Medicine stock which is close to launching a novel diabetes drug?